Ausgabe 12/2019
Inhalt (23 Artikel)
Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer
Chunyan Li, Lin Zhang, Guangping Meng, Qi Wang, Xuejiao Lv, Jie Zhang, Junyao Li
Correlations between microsatellite instability and the biological behaviour of tumours
Guang Yang, Ru-yi Zheng, Zai-shun Jin
Oncogenic potential of nucleoporins in non-hematological cancers: recent update beyond chromosome translocation and gene fusion
Adhiraj Roy, Gopeshwar Narayan
Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer
Ying Wang, Yanxia Liu, Lina Zhang, Li Tong, Yuan Gao, Fanbin Hu, Peter Ping Lin, Baolan Li, Tongmei Zhang
Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma
Xiaolin Peng, Yao Liu, Shan Zhu, Xin Peng, Hui Li, Wenhui Jiao, Peng Lin, Zhe Zhang, Yuling Qiu, Meihua Jin, Ran Wang, Dexin Kong
Are shape morphologies associated with survival? A potential shape-based biomarker predicting survival in lung cancer
Maliazurina Saad, Ik Hyun Lee, Tae-Sun Choi
Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo
Qianqian Jiang, Yue Yuan, Yi Gong, Xinmei Luo, Xiaolan Su, Xueting Hu, Wen Zhu
Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome
Mithalesh Kumar Singh, Lata Singh, Kunzang Chosdol, Neelam Pushker, Neeru Saini, Rachna Meel, Sameer Bakhshi, Seema Sen, Seema Kashyap
Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015–2018
Lidija Stevanovic, Matthias Choschzick, Linda Moskovszky, Zsuzsanna Varga
Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis
Xialing Huang, Liling Long, Jieqin Wei, Yajuan Li, Yuwei Xia, Panli Zuo, Xiangfei Chai
Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer
Yamei Zhao, Xiaoxu Ge, Xiaoming Xu, Shaojun Yu, Jian Wang, Lifeng Sun
Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors
Ning Zhu, Shanshan Weng, Juan Wang, Jiaqi Chen, Linzhen Yu, Xuefeng Fang, Ying Yuan
A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis
Josias Bastian Grogg, Kym Schneider, Peter-Karl Bode, Marian Severin Wettstein, Benedikt Kranzbühler, Daniel Eberli, Tullio Sulser, Joerg Beyer, Thomas Hermanns, Christian Daniel Fankhauser
Increased risk for cancer after stroke at a young age: etiological relevance or incidental finding?
Christian Tanislav, Charles Christian Adarkwah, Louis Jakob, Karel Kostev
PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy
Zhenlin Yang, Jiachen Xu, Renda Li, Yibo Gao, Jie He
Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas
Frank Kroschinsky, Denise Röllig, Barbara Riemer, Michael Kramer, Rainer Ordemann, Johannes Schetelig, Martin Bornhäuser, Gerhard Ehninger, Mathias Hänel
ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression
Maria-Alexandra Papadimitriou, Margaritis Avgeris, Panagiotis K. Levis, Theodoros Tokas, Konstantinos Stravodimos, Andreas Scorilas
The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine
Cai Xiu, Xiao Li, Lingyun Wu, Feng Xu, Qi He, Zheng Zhang, Dong Wu, Luxi Song, Jiying Su, Liyu Zhou, Youshan Zhao, Ying Tao, Chunkang Chang
Brain metastasis as exclusion criteria in clinical trials involving extensive-stage small cell lung cancer
Andy Wang, Takefumi Komiya
Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer
H. Vihervuori, T. A. Autere, H. Repo, S. Kurki, L. Kallio, M. M. Lintunen, K. Talvinen, P. Kronqvist
The effectiveness of Wilms tumor screening in Beckwith–Wiedemann spectrum
Alessandro Mussa, Kelly A. Duffy, Diana Carli, Jessica R. Griff, Riccardo Fagiano, Jonida Kupa, Garrett M. Brodeur, Giovanni Battista Ferrero, Jennifer M. Kalish
“Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation”
Neval E. Wareham, Qiuju Li, Henrik Sengeløv, Caspar Da Cunha-Bang, Finn Gustafsson, Carsten Heilmann, Michael Perch, Allan Rasmussen, Søren Schwartz Sørensen, Amanda Mocroft, Jens D. Lundgren